EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, ORYZF: Oryzon Genomics Sa

17 Nov 2025
LAST:

3.360

CHANGE:
 0.25		OPEN:
3.360		HIGH:
3.360		ASK:
0.000		VOLUME:
100
CHG(%):
6.93		PREV:
3.610		LOW:
3.360		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

PROFILE

Name:Oryzon Genomics Sa
About:Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases. The company was founded in 2000 and is based in Cornellà de Llobregat, Spain.
Sector:Healthcare
Industry:Biotechnology
Address:Sant Ferran 74, Cornellà de Llobregat, Spain, 08940
Website:https://www.oryzon.com
FIGI:BBG00R4RWLB2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:3.607.2%
MA10:3.360.0%
MA20:2.7124.2%
STO9:24.54
STO14:63.75
RSI14:69.42 
WPR14:-36.25
MTM14:1.79
ROC14:1.13 
ATR:0.33 
Week High:3.360.0%
Week Low:3.360.0%
Month High:3.360.0%
Month Low:3.36